Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2026-01-14 @ 3:09 AM
Study NCT ID:
NCT04793568
Status:
UNKNOWN
Last Update Posted:
2022-02-16
First Post:
2021-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study
Sponsor:
Nantes University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-24
First Submit QC Date:
None
Study First Post Date:
2021-03-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-01
Last Update Post Date:
2022-02-16
Last Update Post Date Type:
ACTUAL